Summary
We have investigated neurotransmitter-related markers of the cerebrospinal fluid (CSF) in a carefully screened series of normally aging subjects in standardized conditions in order to find out the influence of age and other confounding factors on CSF measures. The levels of 3-methoxy-4-hydroxyglycol (MHPG) and the activity of acetylcholinesterase (AChE) also increased with age, while homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5 HIAA) and immunoreactivities of somatostatin (SLI), beta-endorphin (BLI) and adrenocorticotropic hormone (ACTH) were unrelated to age. The gender of subjects had no significant effect on the levels of neurotransmitter markers, while seasonal changes, as well as height and weight of the subjects seemed to cause some variations in the levels of HVA, dopamine-Β-hydroxylase (DBH) and ACTH. The study underscores the importance of standardized conditions and matched patient groups in the CSF studies.
Similar content being viewed by others
References
Alessio L, Govoni S, Salar G, Battaini F, Iavicolli R, Trabucci M (1988) Age-related changes of methione-enkephalin and beta-endorphin/beta-lipotropin immunoreactivity in human CSF. Life Sci 43: 1545–1550
åsberg M, Bertilsson L, Rydin E, Scalling D, Thoren P, Traskman-Bendz L (1981) Monoamine metabolites in cerebrospinal fluid in relation to depressive illness, suicidal behaviour and personality. In: Anquist B, Burrows GD, Lader M, Lingjaerde O, Sedwall G, Wheatley D (eds) Recent advances in biosciences. Pergamon Press, New York, pp 257–271
Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH (1986) Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J Neurochem 47: 263–277
Atack JR, Perry EK, Bonham JR, Perry RH (1987) Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid. J Neurochem 48: 1845–1850
Atack JR, Beal MF, May C, Kaye JA, Mazurek MF, Kay AD, Rapoport SI (1988) Cerebrospinal fluid somatostatin and neuropeptide Y concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs. Arch Neurol 45: 269–274
Ballenger JC, Post RM, Goodwin FK (1983) Neurochemistry of cerebrospinal fluid in normal individuals. Relationship between biological and psychological variables. In: Wood JH (ed) Neurobiology of cerebrospinal fluid, 2nd edn. Plenum Press, New York, pp 143–155
Banki C (1977) Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disorders. J Neurochem 28: 255–257
Bareggi SR, Franceschi M, Bonini L, Zecca L, Smirne S (1982) Decreased CSF concentration of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Arch Neurol 39: 709–712
Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408–417
Beal MF, Martin JB (1986) Neuropeptides in neurological disease. Ann Neurol 20: 547–565
Beal MF, Growdon JH, Mazurek MF, Martin JB (1986) CSF somatostain-like immunoreactivity in dementia. Neurology 36: 294–297
Ben Menachem E, Persson L, Schecter PJ, Haegele KD, Huebert N, Hardenberg J (1989) Cerebrospinal fluid parameters in healthy volunteers during serial lumbar punctures. J Neurochem 52: 632–635
Bowers ME (1968) 5-Hydroxyindolacetic acid in the brain and cerebrospinal fluid of the rabbit following administration of drugs affecting 5-hydroxytryptamine. J Neurochem 17: 827–828
Bradford H (1986) Neuropeptides: the rising generation of neuroactive substances. In: Bradford H (ed) Chemical neurobiology: an introduction to neurochemistry, 1st edn. Freeman and Company, New York, p 276
Bulat M (1977) On the cerebrospinal origin of 5-hydroxyindoleactic acid in the lumbar cerebrospinal fluid. Brain Res 122: 388–391
Carlsson A, Svennerholm L, Winblad B (1980) Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiatr Scand [Suppl 280]: 75–85
Cramer H, Schnaudt D, Rissler K, Strubel D, Wartner JM, Kuntzmann F (1985) Somatostatin-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus. J Neurol 232: 346–351
Damluji S, Rees LH (1987) Effects of catecholamines on secretion of adrenocorticotrophic hormone (ACTH) in man. J Clin Pathol 40: 1098–1107
Davis KL, Hollister LE, Mathe AA, Davis BM, Rothpearl AB, Faul KF, Hsieh JY-K, Barchas JD, Berger PA (1981) Neuroendocrine and neurochemical measurements in depression. Am J Psychiatry 138: 1555–1562
DeKosky ST, Scheff SW, Markesbery WR (1985) Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging. Neurology 35: 1425–1430
Delfs JR, Zhu C-H, Dichter MA (1984) Coexistence of acetylcholinesterase and somatostatin-like immunoreactivity in neurons cultured from rat cerebrum. Science 223: 61–63
Deutsch SI, Mohs RC, Levy MI, Rothpearl AB, Stocton B, Hovarth T, Coco A, Davis KL (1983) Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normals. Biol Psychiatry 18: 1363–1373
Elble R, Giacobini E, Scarsella GF (1987) Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer's disease. Arch Neurol 44: 403–407
Ellman GL, Courtney K, Anders V Jr, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88–95
Faccinetti F, Nappi G, Petraglia F, Martignoni E, Sinforiani E, Genazzani AR (1984) Central ACTH deficit in degenerative and vascular dementia. Life Sci 35: 1691–1697
Gottfries CG, Gottfries I, Roos BE (1970) Homovanillic acid and 5-hydroxyindolacetic acid in cerebrospinal fluid related to rated mental and motor impairment in senile and presenile dementia. Acta Psychiatr Scand 46: 99–105
Gottfries CG, Gottfries I, Johansson B, Olsson R, Persson T, Roos B-E, Sjoström R (1971) Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. Neuropharmacology 10: 665–672
Gottfries CG, Roos BE (1973) Acid monoamine metabolites in cerebrospinal fluid from patients with presenile dementia (Alzheimer's disease). Acta Psychiatr Scand 49: 257–263
Growdon JH, Gorkin S (1983) Cerebrospinal fluid measures in Alzheimer's disease. In: Crook T, Ferris S, Bartus R (eds) Assessment in geriatric psychopharmacology. Mark Powley Associates, Connecticut, pp 251–262
Guthrie SK, Berrettini W, Rubinow DR, Nurnberger JI, Bartko JJ, Linnoila M (1986) Different neurotransmitter metabolite concentrations in CSF samples from inpatient and outpatient normal volunteers. Acta Psychiatr Scand 73: 315–321
Jolkkonen J, Lehtinen M, Soininen H, Sennef C, Riekkinen P (1987) Enhanced monoaminergic neurotransmission by desglycinamide-arginine-vasopressin in human subjects. Neurosci Lett 76: 312–315
Jolkkonen JT, Soininen HS, Riekkinen PJ (1987) B-endorphin-like immunoreactivity in cerebrospinal fluid of patients with Alzheimer's disease and Parkinson's disease. J Neurol Sci 77: 153–159
Kaiya H, Tanaka H, Takeuchi K, Morita K, Adachi S, Shirakawa H, Ueki H, Namba M (1983) Decreased level of B-endorphin-like immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Life Sci 33: 1039–1043
Kopin IJ, Gordon EK, Jimerson DC, Polinsky RJ (1983) Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol. Science 219: 73–75
Kornhuber J, Kaiserauer CH, Kornhuber AW, Kornhuber ME (1987) Alcohol consumption and blood-cerebrospinal fluid barrier dysfunction in man. Neurosci Lett 79: 218–222
Karson NG, Berman FK, Kleinman J, Karoum F (1984) Seasonal variation in human central dopamine activity. Psychiatry Res 11: 111–117
Lal S, Wood PL, Kiely ME, Etienne P, Gauthier S, Stradford J, Ford RM, Dastoor D, Nair NPV (1984) CSF Acetylcholinesterase in dementia and in sequential samples of lumbar CSF. Neurobiol Aging 5: 269–274
Losonczy MF, Mohs RC, Davies KL (1984) Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations. Psychiatry Res 12: 79–87
Lowry OH, Rosenbrough NJ, Farr AL, Randall RS (1951) Protein measurement with the Folin phenol method. J Biol Chem 193: 265–275
Masters CL, Bayreuther K (1988) The blood-brain-barrier in Alzheimer's disease and normal aging. Neurobiol Aging 9: 43–44
May C, Rapoport SI, Tomai TP, Chrousos GP, Gold PW (1987) Cerebrospinal fluid concentrations of corticotropin releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease. Neurology 37: 535–538
Mooradian AD (1989) Effect of aging on the blood-brain barrier. Neurobiol Aging 9: 31–39
Nakamura S, Vincent SR (1985) Acetylcholinesterase and somatostatin-immunoreactivity coexist in human neocortex. Neurosci Lett 61: 183–187
Nicoletti F, Raffaele R, Falsaperla A, Paci R (1981) Circadian variation in 5-hydroxyindoleacetic acid levels in human cerebrospinal fluid. Eur Neurol 20: 9–12
Oldendorf W (1988) Other likely BBB functions possibly related to aging. Neurobiol Aging 9: 52
Palmer A, Sims R, Bowen DM (1984) Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients in histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry 47: 481–484
Post RM, Kotin J, Goodwin FK, Gordon EK (1973) Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry 130: 67–72
Raconczay Z, Kasa P, Sirviö J, Riekkinen PJ (1989) Activity and molecular forms of cerebrospinal fluid acetylcholinesterase in normal aging, Alzheimer's disease, and amyotrophic lateral sclerosis. Abstracts of the 12th Annual Meeting of the European Neuroscience Association, Turin 1989 (Eur J Neurosci [Suppl 2]: 238)
Raskind MA, Peskind ER, Halter JB, Jimerson DC (1984) Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease. Arch Gen Psychiatry 41: 343–346
Reinikainen K, PaljÄrvi L, Halonen T, Malminen O, Kosma V-M, Laakso M, Riekkinen PJ (1988) Dopaminergic system and monoamine-oxidase-B activity in Alzheimer's disease. Neurobiol Aging 9: 245–252
Reinikainen KJ, Riekkinen PJ, PaljÄrvi L, Soininen H, Helkala E-L, Jolkkonen J, Laakso M (1988) Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data. Neurochem Res 13: 135–146
Reinikainen KJ, Riekkinen PJ (1990) Noncholinergic neurotransmitter markers in the CSF of patients with dementia of Alzheimer type. In: Fowler CJ, Carlson LA, Gottfries C-G, Winblad B (eds) Biological markers in dementia of Alzheimer type. Aging and aging disorders No. 1. Smith-Gordon Nishimura, London, pp 161–178
Riekkinen P Jr, Miettinen R, Rummukainen J, PitkÄnen A, PaljÄrvi L, Riekkinen P (1990) The effects of lesioning the basal forebrain cholinergic neurones on CSF AChE activity. Neurosci Res 6: 37–43
Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A (1980) Pathological verification of ischaemic score in differentiation of dementias. Ann Neurol 7: 486–488
Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport V, Mueller PS, Newsome DA, Wehr TA (1984) Seasonal affective disorder. Arch Gen Psychiatry 41: 72–80
Sirviö J, Kutvonen R, Hartikainen P, Riekkinen PJ (1989) Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease. J Neural Transm 75: 119–127
Sjostrom R, Ekstedt J, Anggard E (1975) Concentration gradients of monoamine metabolites in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry 38: 666–668
Smith AD, Cuello AC (1984) Alzheimer's disease and acetylcholinesterase-containing neurons. Lancet i: 513
Soininen HS, Halonen T, Riekkinen PJ (1981a) Acetylcholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Acta Neurol Scand 64: 217–224
Soininen H, MacDonald E, Rekonen M, Riekkinen PJ (1981) Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Acta Neurol Scand 64: 101–107
Soininen HS, Jolkkonen J, Reinikainen KJ, Halonen TO, Riekkinen PJ (1984) Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of Alzheimer type. J Neurol Sci 63: 167–172
Soininen H, PitkÄnen A, Halonen T, Riekkinen PJ (1984) Dopamine-Β-hydroxylase and acetylcholinesterase activities in cerebrospinal fluid in Alzheimer's disease. Acta Neurol Scand 69: 29–34
Stahl M, Faull F, Barchas JD, Berger PA (1985) CSF Monoamine metabolites in movement disorders and normal aging. Arch Neurol 42: 166–169
Sunderland T, Rubinow DR, Tariot PN, Cohen RM, Newhouse PA, Mellow AM, Mueller EA, Murphy DL (1987) CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects. Am J Psychiatry 144: 1313–1316
Tune L, Gucker S, Folstein M, Oshida L, Coyle JT (1985) Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type. Ann Neurol 17: 46–48
Volicer L, Beal MF, Direnfeld LK, Marquis JK, Albert ML (1986) CSF cyclic nucleotides and somatostatin in Parkinson's disease. Neurology 36: 89–92
Wirz-Justice A, Richter R (1979) Seasonality in biochemical determinations: a source of variation and clue to the temporal incidence of affective disorders. Psychiatry Res 1: 53–60
Wode-Helgodt B, Sedwall G (1978) Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women. Psychopharmacology 2: 177–183
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hartikainen, P., Soininen, H., Reinikainen, K.J. et al. Neurotransmitter markers in the cerebrospinal fluid of normal subjects effects of aging and other confounding factors. J. Neural Transmission 84, 103–117 (1991). https://doi.org/10.1007/BF01249114
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01249114